MCA Stability Tool

Find stability recommendations for tablets and capsules.

Product Search

Stability Notes

This medicinal product does not require any special storage conditions.

Provenance

This compatibility recommendation is derived from Diamicron 30mg MR tablets (Servier Laboratories Ltd).

Stability Notes

Zidovudine not adversely affected by short-term exposure to heat and sunlight. Capsules may become discolored or brittle and should be protected from light, heat, and moisture.

Provenance

This compatibility recommendation is derived from Retrovir 100mg capsules (ViiV Healthcare UK Ltd)

Stability Notes

Zidovudine not adversely affected by short-term exposure to heat and sunlight. Capsules may become discolored or brittle and should be protected from light, heat, and moisture.

Provenance

This compatibility recommendation is derived from Retrovir 250mg capsules (ViiV Healthcare UK Ltd)

Stability Notes

Protect from light and store in an airtight container.

Provenance

This compatibility recommendation is derived from Combivir 150mg/300mg tablets (ViiV Healthcare UK Ltd).

Stability Notes

Protect from light and store in an airtight container.

Provenance

This compatibility recommendation is derived from Combivir 150mg/300mg tablets (ViiV Healthcare UK Ltd).

Stability Notes

Protect from light. Protect from moisture. Max 28 days in MCA.

Provenance

This compatibility recommendation is derived from Zimovane 7.5mg tablets (Sanofi) and Zopiclone 7.5mg tablets (Accord Healthcare Ltd).

Stability Notes

Store in an airtight container.

Provenance

This compatibility recommendation is derived from Zinamide 500mg tablets (Genus Pharmaceuticals Ltd).

Print this list

Medicines under this category are suitable for use inside MCAs, although this is likely to be an off-label use.
Medicines under this category can theoretically be used inside an MCA; however, mitigations may need to be considered.
Medicines under this category are not suitable for use inside MCAs.
We do not have stability information for these medicines and therefore cannot make a recommendation on suitability in an MCA.